A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells

BACKGROUND: Pathologic vascular smooth muscle cell (VSMC) proliferation and migration after vascular injury promotes the development of occlusive vascular disease. Therefore, an effective chemical agent to suppress aberrant proliferation and migration of VSMCs can be a potential therapeutic modality...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Hyang-Hee, Kim, Sang Woo, Lee, Chang Youn, Lim, Kyu Hee, Lee, Jiyun, Choi, Eunhyun, Lim, Soyeon, Lee, Seahyoung, Hwang, Ki-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244549/
https://www.ncbi.nlm.nih.gov/pubmed/28100269
http://dx.doi.org/10.1186/s40659-016-0106-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244549/
https://www.ncbi.nlm.nih.gov/pubmed/28100269
http://dx.doi.org/10.1186/s40659-016-0106-3

Ejemplares similares